Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.88 |
| ▸ | TGM2 | P21980 | 1/20 | 0.68 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.61 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.55 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.55 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8674198 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL2876850 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL3693087 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL3287016 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL3694316 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL4857273 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL4858734 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL2875581 | 1.00 | HTT (0.88) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4438046 | 0.98 | HTT (0.86) | HTTTGM2FOLH1LMNASMN1; SMN2 | |
| SCHEMBL879577 | 0.98 | HTT (0.91) | HTTTGM2FOLH1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119912519-A | Double-target targeted polypeptide compound, preparation method and application | 中国人民解放军总医院第一医学中心 | 2025-05-02 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | claimed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | claimed |
| US-9045513-B2 | Method for preparing precursor used for labeling hepatocyte receptor and containing trisaccharide and DTPA ligand | Atomic Energy Council—Institute of Nuclear Energy Research (TW) | 2015-06-02 | — | — | US | claimed |
| US-8809581-B2 | Method of making 6-aminocaproic acid as active pharmaceutical ingredient | Sunny Pharmtech Inc. (TW) | 2014-08-19 | — | — | US | claimed |
| US-20140046045-A1 | METHOD FOR PREPARING PRECURSOR USED FOR LABELING HEPATOCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DTPA LIGAND | ATOMIC ENERGY COUNCIL - INSTITUTE OF NUCLEAR ENERGY RESEARCH (TW) | 2014-02-13 | — | — | US | claimed |
| US-20140039219-A1 | Method of Making 6-Aminocaproic Acid As Active Pharmaceutical Ingredient | Sunny Pharmtech Inc. (TW) | 2014-02-06 | — | — | US | claimed |
| US-8481161-B2 | Functionalized metal nanoparticle and method for formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-07-09 | — | — | US | claimed |
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2013-01-24 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| US-7923110-B2 | Metal nanoparticle having a self-assembled monolayer on its surface, and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2011-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-20080020317-A1 | Novel metal nanoparticle and formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-24 | — | — | US | claimed |
| US-20080003363-A1 | Novel metal nanoparticle and method for formation of conductive pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-01-03 | — | — | US | claimed |
| WO-2026099897-A1 | NOVEL LINKERS AND ITS PREPARATION METHODS THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2026-05-15 | — | — | WO | disclosed |
| US-3993609-A | ACID SENSITIVE AZO PROMOTERS | PENNWALT CORPORATION (US) | 1976-11-23 | — | — | US | disclosed |
| US-3935266-A | BRADYKININ AND HISTAMINE ANTAGONIST, ANTIINFLAMMATORY | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JA) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140046045-A1 | METHOD FOR PREPARING PRECURSOR USED FOR LABELING HEPATOCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DTPA LIGAND | HDGF, NR1H4, TRHR | HTT 4257/4885TGM2 989/4885FOLH1 693/4885 |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | HTT 1387/4885TGM2 1287/4885FOLH1 2209/4885 |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | HTT 1387/4885TGM2 1287/4885FOLH1 2209/4885 |
| US-20140039219-A1 | Method of Making 6-Aminocaproic Acid As Active Pharmaceutical Ingredient | APEH, ACMSD, AASDHPPT | HTT 651/4885TGM2 1387/4885FOLH1 627/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | HTT 1387/4885TGM2 1287/4885FOLH1 2209/4885 |
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | PIGS, ENPEP, DNPEP | HTT 2783/4885TGM2 840/4885FOLH1 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.